---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-008691"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T01:23:45.090346+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# ChromaDex amends CEO Fried's contract to $650k base, grants 1.5M PSUs with $15-$50 stock price targets

## Summary
- Base salary increased to $650,000 effective Jan 1, 2025; target bonus raised to 75% of base for FY2025.
- CEO granted 1,518,600 PSUs with 7-year performance period; vest at stock price thresholds of $15, $20, $30, $40, $50.
- First tranche (759,300 PSUs) vests at $15 VWAP for 60 trading days; subsequent 189,825 each at higher thresholds.
- PSUs subject to five-year transfer restriction after vesting; no cash-out feature; forfeiture if targets not met by 2032.
- Under termination without cause or for good reason, unvested PSUs remain eligible for 12 months; transfer restrictions lapse.

## SEC filing metadata
- accession: 0001628280-25-008691
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828025008691/0001628280-25-008691-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828025008691/cdxc-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-008691
- JSON: https://secwatch.observer/filing/0001628280-25-008691.json
- Plain text: https://secwatch.observer/filing/0001628280-25-008691.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.